Discriminative performance of pancreatic stone protein in predicting ICU mortality and infection severity in adult patients with infection: a systematic review and individual patient level meta-analysis
Authors:
Open Access
- 14 September 2023
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 51 (6) , 1797-1807
Abstract
Background: Several studies suggested pancreatic stone protein (PSP) as a promising biomarker to predict mortality among patients with severe infection. The objective of the study was to evaluate the performance of PSP in predicting intensive care unit (ICU) mortality and infection severity among critically ill adults admitted to the hospital for infection.Methods: A systematic search across Cochrane Central Register of Controlled Trials and MEDLINE databases (1966 to February 2022) for studies on PSP published in English using ‘pancreatic stone protein’, ‘PSP’, ‘regenerative protein’, ‘lithostatin’ combined with ‘infection’ and ‘sepsis’ found 46 records. The search was restricted to the five trials that measured PSP using the enzyme-linked immunosorbent assay technique (ELISA). We used Bayesian hierarchical regression models for pooled estimates and to predict mortality or disease severity using PSP, C-Reactive Protein (CRP) and procalcitonin (PCT) as main predictor. We used statistical discriminative measures, such as the area under the receiver operating characteristic curve (AUC) and classification plots.Results: Among the 678 patients included, the pooled ICU mortality was 17.8% (95% prediction interval 4.1% to 54.6%) with a between-study heterogeneity (I-squared 87%). PSP was strongly associated with ICU mortality (OR = 2.7, 95% credible interval (CrI) [1.3–6.0] per one standard deviation increase; age, gender and sepsis severity adjusted OR = 1.5, 95% CrI [0.98–2.8]). The AUC was 0.69 for PSP 95% confidence interval (CI) [0.64–0.74], 0.61 [0.56–0.66] for PCT and 0.52 [0.47–0.57] for CRP. The sensitivity was 0.96, 0.52, 0.30 for risk thresholds 0.1, 0.2 and 0.3; respective false positive rate values were 0.84, 0.25, 0.10.Conclusions: We found that PSP showed a very good discriminative ability for both investigated study endpoints ICU mortality and infection severity; better in comparison to CRP, similar to PCT. Combinations of biomarkers did not improve their predictive ability.Keywords
Funding Information
- University of Bern
This publication has 51 references indexed in Scilit:
- Pancreatic Stone Protein Predicts Outcome in Patients With Peritonitis in the ICU*Critical Care Medicine, 2013
- The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and deathResuscitation, 2013
- Sepsis biomarkers in unselected patients on admission to intensive or high-dependency careCritical Care, 2013
- The potential impact of biomarker-guided triage decisions for patients with urinary tract infectionsInfection, 2013
- Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-AnalysisClinical Infectious Diseases, 2012
- Pancreatic Stone ProteinChest, 2011
- Procalcitonin Algorithms for Antibiotic Therapy DecisionsArchives of internal medicine (1960), 2011
- Sepsis biomarkers: a reviewCritical Care, 2010
- Pancreatic stone protein is highly increased during posttraumatic sepsis and activates neutrophil granulocytes*Critical Care Medicine, 2009
- Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2004